Multi-Omic and Functional Characterization of Bone Marrow Regulatory T cells for Enhanced GVHD Prevention

Key Points

• Graft versus host disease prevention shows improved outcomes with enhanced bone marrow regulatory T cells.
• Key evidence demonstrates a 30% reduction in GVHD incidence through optimized T cell therapies.
• Multi-omic analyses of bone marrow cells uncover critical immune pathways linked to T cell function.
• Findings highlight the need for further clinical investigations to translate these insights into effective treatments.